Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alere Inc (NYSE:ALR)

Delayed Data
As of Aug 18
 +0.22 / +0.45%
Today’s Change
Today|||52-Week Range
Health Technology
Pharmaceuticals: Other

Company Description

Alere, Inc. engages in developing, manufacturing, and marketing consumer and professional medical diagnostic products. It operates through the following segments: Professional Diagnostics, Consumer Diagnostics, and Other Non-Reportable. The Professional Diagnostics segment includes an array of diagnostic test products and other in vitro diagnostic tests. The Consumer Diagnostics segment consists of manufacturing operations. The Other Non-Reportable segment includes Alere Home Monitoring, which distributes PT and INR coagulation; monitors and facilitates the distribution of equipment; and supplies to power and control customers' implanted ventricular assist devices and VADs. It also provides telemonitoring services that allow VAD coordinators to monitor patients soon after discharge and receive alerts when critical patient values fall outside pre-established ranges. The company was founded by Ronald Zwanziger on May 11, 2001 and is headquartered in Waltham, MA.

Contact Information

Alere, Inc.
51 Sawyer Road
Waltham Massachusetts 02453
P:(781) 647-3900
Investor Relations:
(858) 805-2232



Individual stakeholders6.82%
Other institutional56.77%
Mutual fund holders33.68%

Top Executives

Namal NawanaPresident, Chief Executive Officer & Director
Mark GladwellSenior Vice President-Global Operations
Jim HinrichsChief Financial Officer & Executive Vice President
Renuka UppaluriSenior Vice President-Research & Development
Ellen V. ChiniaraSecretary, Chief Ethics & Compliance Officer, SVP